Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-25-002857
Filing Date
2025-01-29
Accepted
2025-01-28 17:36:22
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A noticeofinternetavailabi.htm DEFA14A 2381
2 noticeofinternetavailabi001.jpg GRAPHIC 88589
3 noticeofinternetavailabi002.jpg GRAPHIC 148218
4 noticeofinternetavailabi003.jpg GRAPHIC 118050
  Complete submission text file 0001628280-25-002857.txt   492632
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38042 | Film No.: 25565946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)